|In vitro (25°C)||DMSO||92 mg/mL (199.78 mM)|
|Water||<1 mg/mL (<1 mM)|
|Ethanol||<1 mg/mL (<1 mM)|
|In vivo||0.5% CMC/0.25% Tween 80||30 mg/mL|
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.1 mM||21.72 mL||108.58 mL||217.16 mL|
|0.5 mM||4.34 mL||21.72 mL||43.43 mL|
|1 mM||2.17 mL||10.86 mL||21.72 mL|
|5 mM||0.43 mL||2.17 mL||4.34 mL|
*The above data is based on the productmolecular weight 460.5 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|MECHANISM OF ACTION||Inhibitor|
|Storage||at -20°C 3 years Powder|
QNZ inhibits the activation of the transcription factor NF-κB and has been used to investigate NF-κB signaling.
Lenalidomide is a derivative of thalidomide. In vitro, lenalidomide has three main activities: direct anti-tumor effect, inhibition of the m…
Necrostatin-1 is an ATP-competitive, allosteric inhibitor of receptor-interacting protein kinase 1 (RIPK1) (EC50 = 182 nM).